Table 2 Transplant characteristics
Transplant characteristics | N = 361 (%) |
|---|---|
Transplant Indication | |
Biliary Atresia | 76 (21) |
Progressive Familial Intrahepatic Cholestasis | 69 (20) |
Neonatal Cholestasis | 29 (8) |
Arginosuccinate Aciduria | 19 (5) |
Sclerosing Cholangitis | 18 (5) |
Acute fulminant Liver Failure | 17 (5) |
Glycogen Storage Disease | 16 (4) |
Alagille Syndrome | 16 (4) |
Propionic Acidemia | 13 (4) |
Crigler Najjar Syndrome | 12 (3) |
Maple Syrup Urine Disease | 12 (3) |
Primary hyperoxaluria | 9 (2) |
Tyrosinemia | 8 (2) |
Autoimmune Hepatitis | 6 (2) |
Hepatoblastoma | 6 (2) |
Citrullinemia | 6 (2) |
Choledochal Cyst | 4 (1) |
Hemochromatosis | 3 (1) |
Other | 22 (6) |
Donor | |
Living Donor | 336 (93) |
Deceased Donor | 25 (7) |
Donor Related | 62 (17) |
Post-Operative Surgical Complications | |
Chylous Ascites | 32 (9) |
Pleural Effusion | 10 (3) |
Massive Hemorrhage | 9 (2) |
Abdominal Hematoma | 4 (1) |
Perihepatic Collection | 4 (1) |
Abdominal Collection | 3 (1) |
Hepatic Biloma | 2 (0.5) |
Atelectasis | 2 (0.5) |
Biliary Leak | 2 (0.5) |
Other | 19 (5) |
Length of Stay Post Transplant (days) | 29.7 ± 18.7 |